CHRISTOPHER P. ALBERGO
MURFREESBORO, TN
Browse related groups: TN Corcept Therapeutics All categories
This page merges CMS profile IDs: 7226552, 7583914 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$7,954.32
- Category: General Payments
- Program years: PY2019–2024
- Record count: 321
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,206.53 across 50 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,206.53 | 50 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Corcept Therapeutics | $163.06 | 2 |
| CeQur Corporation | $112.88 | 1 |
| Averitas Pharma Inc. | $88.73 | 3 |
| Insulet Corporation | $69.41 | 3 |
| Abbott Laboratories | $69.29 | 2 |
| ABBVIE INC. | $67.11 | 3 |
| Medtronic, Inc. | $66.85 | 4 |
| Amgen Inc. | $62.22 | 3 |
| Antares Pharma, Inc. | $54.18 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $40.88 | 2 |
| Radius Health, Inc. | $39.43 | 2 |
| Lundbeck LLC | $37.70 | 2 |
| EMD Serono, Inc. | $29.24 | 2 |
| Ultragenyx Pharmaceutical Inc. | $29.18 | 1 |
| Lilly USA, LLC | $28.14 | 2 |
| Novo Nordisk AS | $20.77 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.10 | 1 |
| Amneal Pharmaceuticals LLC | $18.70 | 1 |
| PFIZER INC. | $18.62 | 1 |
| Neurocrine BioSciences, Inc. | $18.35 | 1 |
| SANOFI-AVENTIS U.S. LLC | $17.84 | 1 |
| Verity Pharmaceuticals Inc. | $17.82 | 1 |
| Alexion Pharmaceuticals, Inc. | $15.54 | 1 |
| Esperion Therapeutics, Inc. | $14.88 | 1 |
| Tandem Diabetes Care, Inc. | $14.78 | 1 |
| Currax Pharmaceuticals LLC | $14.74 | 1 |
| DEXCOM, INC. | $14.72 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.35 | 1 |
| JAZZ PHARMACEUTICALS INC. | $14.16 | 1 |
| Azurity Pharmaceuticals, Inc. | $13.86 | 1 |
By program year
Records — PY2024 (50)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 7226552, 7583914
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.